Hahnemann'S Jac Olivol Group Of Products Profile
Key Indicators
- Authorised Capital ₹ 0.30 M
as on 10-12-2024
- Paid Up Capital ₹ 0.30 M
as on 10-12-2024
- Company Age 3 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
About Hahnemann'S Jac Olivol Group Of Products
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.30 M and a paid-up capital of Rs 0.30 M, as per Ministry of Corporate Affairs (MCA) records.
Rajarshi Das, Ritesh Das, and Tapati Das serve as directors at the Company.
- CIN/LLPIN
U24232WB2021PTC245072
- Company No.
245072
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 May 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Hahnemann'S Jac Olivol Group Of Products?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajarshi Das  | Director | 30-Apr-2024 | Current |
| Ritesh Das | Director | 30-Apr-2024 | Current |
| Tapati Das | Director | 01-Mar-2024 | Current |
Financial Performance of Hahnemann'S Jac Olivol Group Of Products.
Enhance accessibility to Hahnemann'S Jac Olivol Group Of Products's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Hahnemann'S Jac Olivol Group Of Products?
Unlock access to Hahnemann'S Jac Olivol Group Of Products's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Tapati Domestic Products LlpActive 7 years 9 months
Rajarshi Das, Ritesh Das and 1 more are mutual person
- Hahnemann Laboratory Drugs & Cosmetics Private LimitedActive 2 years 3 months
Rajarshi Das, Ritesh Das and 1 more are mutual person
- Aar - Dee International Private LimitedActive 26 years 6 months
Rajarshi Das and Tapati Das are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Hahnemann'S Jac Olivol Group Of Products?
Hahnemann'S Jac Olivol Group Of Products has a workforce of 12 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hahnemann'S Jac Olivol Group Of Products, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hahnemann'S Jac Olivol Group Of Products's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
